Related Experiment Video
Updated: Aug 8, 2026
In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection
Published on: November 27, 2014
Transient CD80 expression defect in a patient with variable immunodeficiency and cyclic neutropenia
C Moser1, M Schlesier, R Dräger
1Abt. Rheumatologie und Klinische Immunologie, Medizinische Universitätsklinik, Freiburg, Germany.
Insights
This study highlights a unique Common Variable Immunodeficiency (CVID) patient with a temporary CD80 expression defect on B cells, linked to cyclic neutropenia and infections. Recovery improved B cell function and immunoglobulin production.
Area of Science:
- Immunology
- Clinical Medicine
Background:
- Common Variable Immunodeficiency (CVID) is a primary immunodeficiency characterized by hypogammaglobulinemia.
- B cell defects, including impaired CD80 expression, can contribute to CVID pathogenesis.
Observation:
- An exceptional CVID patient presented with cyclic neutropenia, skin vasculitis, and recurrent infections.
- This patient exhibited a transient, reproducible CD80 expression defect on stimulated B cells.
Findings:
- The CD80 expression defect was associated with reduced serum immunoglobulin (Ig) levels and low B cell counts.
- Following recovery from neutropenia and vasculitis, CD80 expression improved, B cell numbers increased, and IgM and IgG production recovered.
Implications:
- This case suggests a potential role for CD80 in B cell function within specific CVID phenotypes.
- Understanding transient immune defects may offer new therapeutic targets for immunodeficiency disorders.
Abstract:
CD80 expression on stimulated B cells of 9 common variable immunodeficiency (CVID) patients and 10 healthy control individuals was examined. Here we report on an exceptional CVID patient with recurrent episodes of cyclic neutropenia, skin vasculitis and recurrent infections associated with a transient, but reproducible CD80 expression defect on stimulated B cells. Concomitantly serum Ig levels were markedly reduced and B cell counts were low. Interestingly, after recovery from an episode of neutropenia and vasculitis we observed an improvement of the CD80 expression as well as an increase in the number of B cells and a recovery of IgM and IgG production in vivo and in vitro.
